AI assistant
Sending…
ALLIANCE PHARMA PLC — Major Shareholding Notification 2016
Nov 17, 2016
7478_mrq_2016-11-17_77de938a-01de-4ae5-8acc-bd876ebf4946.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5091P
Alliance Pharma PLC
17 November 2016
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Alliance Pharma plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | √ | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | √ | |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | ||||
| 3. Full name of person(s) subject to the notification obligation: |
Aviva plc & its subsidiaries | |||
| 4. Full name of shareholder(s) (if different from 3.): | Registered Holder: Available on request 18,450* BNY Norwich Union Nominees Limited 2,744,814* Chase (GA Group) Nominees Limited 38,963,722* *denotes direct interest Chase Nominees Limited 1,382,120 |
|||
| 5. Date of the transaction and date on which the threshold is crossed or reached: |
15 November 2016 | |||
| 6. Date on which issuer notified: | 16 November 2016 | |||
| 7. Threshold(s) that is/are crossed or reached: |
9% to 8% Change at Direct Interest Level (Box 8A) | |||
| 8. Notified details: | |||||||||||
| A: Voting rights attached to shares | |||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights | |||||||
| Direct | Direct | Indirect | Direct | Indirect | |||||||
| Ordinary Shares GB0031030819 |
45,033,531* | 45,033,531* | 43,109,106 | 41,726,986 | 1,382,120 | 8.86% | 0.29% | ||||
| * Includes Right to Recall Loaned Shares (1,080,000) | |||||||||||
| B: Qualifying Financial Instruments | |||||||||||
| Resulting situation after the triggering transaction | |||||||||||
| Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|||||||
| RIGHT TO RECALL LOANED SHARES | N/A | N/A | 1,132,875* *Direct Interest |
0.24% | |||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
| Resulting situation after the triggering transaction | ||||||
| Type of financial instrument |
Exercise price | Expiration date | Exercise/ Conversion period |
Number of voting rights instrument refers to | % of voting rights | |
| Nominal | Delta | |||||
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 44,241,981 | 9.39% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
||
| The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) · Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) · Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) · Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) · Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | See Section 4 | |
| 11. Number of voting rights proxy holder will cease to hold: | ||
| 12. Date on which proxy holder will cease to hold voting rights: | ||
| 13. Additional information: | Figures are based on a total number of voting rights of 471,113,833. | |
| 14. Contact name: | Neil Whittaker, Aviva plc | |
| 15. Contact telephone number: | 01603 684420 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXFXFEFKFFF
More from ALLIANCE PHARMA PLC
Delisting Announcement
2025
May 15
AGM Information
2025
May 14
M&A Activity
2025
May 12
Major Shareholding Notification
2025
May 1
Major Shareholding Notification
2025
Apr 29
Major Shareholding Notification
2025
Apr 29
Director's Dealing
2025
Apr 28
Regulatory Filings
2025
Apr 23
Regulatory Filings
2025
Apr 22
Report Publication Announcement
2025
Apr 9